CoChat

Evaluation of the U.K. 2-week referral rule for skin cancer

Cox, N.H. · 2004 · British Journal of Dermatology
Cited by 49

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In 1997 the U.K. government introduced the target that all patients seen in primary care, and whose general practitioner suspected a possible diagnosis of any cancer, would be seen by a specialist within 2 weeks. Several individual departmental reports suggest that this has generated a high volume of 'urgent' referrals and has been unachievable without impact on other patients. OBJECTIVES: To determine the views of dermatologists, with audit and database information where possible, on the overall impact of the 2-week rule referral standard for suspected skin cancers. METHODS: A questionnaire was sent to consultant dermatologists in the U.K. requesting views and numerical data. RESULTS: There were 139 responses, some on a departmental basis, representing 272 individuals (nearly two-thirds of all consultant dermatologists in post in the U.K). Based on 52 formal audit studies or database information, the overall proportion of confirmed skin cancers among 2-week rule referrals was 12%, but only 42% of tumours were referred by this route. Correct suspicion of melanoma was generally better than that of squamous cell carcinoma. Information on standard referral proformas was only considered to be 'usually adequate' by 34% of departments. Considering all replies, only 27% of respondents felt that the 2-week rule works well; the major problems are an excess of benign lesions, the lack of opportunity to prioritize referrals and the displacement of other urgent problems. CONCLUSIONS: There are significant problems with the perception and application of the 2-week referral standard for possible skin cancers, including a high volume of nonrelevant lesions and displacement of other urgent conditions. Increasing the specificity of referral guidelines, and increased education regarding recognition of benign lesions, are the favoured options for improvement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2133.2004.05793.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 22

  1. 10.1046/j.1365-2133.1999.03111.x · DOI
  2. 10.1046/j.1365-2133.2000.03354.x · doi:10.1046/j.1365-2133.2000.03354.x
  3. 10.1046/j.1365-2133.2000.03346.x · DOI
  4. Shum KW, 2002, Br J Dermatol, 147, 2
  5. 10.1046/j.1365-2133.2002.04814_1.x · doi:10.1046/j.1365-2133.2002.04814_1.x
  6. Naryan S, 2002, Br J Dermatol, 147, 47
  7. 10.1046/j.1365-2133.2002.04919.x · doi:10.1046/j.1365-2133.2002.04919.x
  8. Pearson IC, 2002, Br J Dermatol, 147, 44
  9. Thomson MA, 2003, Br J Dermatol, 149, 28
  10. Leslie KS, 2003, Br J Dermatol, 149, 29, 10.1046/j.0366-077X.2003.05688.x · doi:10.1046/j.0366-077x.2003.05688.x
  11. Hashim N, 2003, Br J Dermatol, 149, 33
  12. Resneck J, 2001, Arch Dermatol, 137, 1295, 10.1001/archderm.137.10.1295 · DOI · Paper page
  13. Suneja T, 2001, Arch Dermatol, 137, 1307, 10.1001/archderm.137.10.1303 · DOI · Paper page
  14. 10.1136/bmj.322.7302.1555 · DOI
  15. 10.1136/gut.48.1.53 · DOI · Paper page
  16. Morris AD, 2003, Br J Dermatol, 148, 608, 10.1046/j.1365-2133.2003.05209_16.x · doi:10.1046/j.1365-2133.2003.05209_16.x
  17. MacKie RM, 1989, Malignant Melanoma. A Guide to Early Diagnosis
  18. 10.1046/j.1365-2133.1999.02823.x · DOI
  19. 10.1136/bmj.321.7255.236 · doi:10.1136/bmj.321.7255.236
  20. 10.1054/brst.1999.0151 · doi:10.1054/brst.1999.0151
  21. Jones R, 2001, Health Service J, 111, 20
  22. 10.1038/35070647 · DOI

Cited by

See all 49

Metadata

Authors
Cox, N. H.
Venue
British Journal of Dermatology
Published
2004-02
Volume
150
Issue
2
Pages
291-298
ISSN
  • 0007-0963 (ISSN-L)
  • 1365-2133
OpenAlex
W1969458739
Cited by
49
References
1
FWCI
1.91
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4230 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of the U.K. 2-week referral rule for skin cancer. https://app.cochat.ai/papers/10.1111/j.1365-2133.2004.05793.x
The paper
Cox, N. H. (2004). Evaluation of the U.K. 2-week referral rule for skin cancer. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2004.05793.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.